Intnl. Biotechnology - Notice of Results and Investor Presentation

International Biotechnology Trust

01/11/2023 15:52

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231101:nRSA0911Sa&default-theme=true

RNS Number : 0911S  Intl. Biotechnology Trust PLC  01 November 2023

1 November 2023

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

("IBT" or the "Company")

Notice of Results and Investor Presentation via Investor Meet Company

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC is pleased to announce that Ailsa Craig
and Marek Poszepczynski will provide a live presentation relating to the
Company's Annual Results via Investor Meet Company on 7th Nov 2023 at 1:30pm
GMT.

The presentation is open to all existing and potential shareholders. Questions
can be submitted pre-event via your Investor Meet Company dashboard up until
9am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet
INTERNATIONAL BIOTECHNOLOGY TRUST PLC via:

https://www.investormeetcompany.com/international-biotechnology-trust-plc/register-investor
(https://www.investormeetcompany.com/international-biotechnology-trust-plc/register-investor)

Investors who already follow INTERNATIONAL BIOTECHNOLOGY TRUST PLC on the
Investor Meet Company platform will automatically be invited.

 

For further information contact:

Company Secretary - Link Company Matters

Indu Shastri                   +44 (0)7936 045789

Director of Investor Relations

Lucy Costa Duarte         +44 (0)7825 511760

 

LEI: 213800N1QUJ744P76D11

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORFLFEELILLIIV